Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Malignant mesenchymal tumor 1Colorectal Neoplasms 1Carcinoma 1Anus Neoplasms 1

Interventions

Nivolumab 5Specimen Handling 4Magnetic Resonance Spectroscopy 4Radiotherapy 3Mitomycin 3Fluorouracil 3Biopsy 3fludarabine phosphate 2fludarabine 2entinostat 2aldesleukin 2Trastuzumab 2Sigmoidoscopy 2Proctoscopy 2Ipilimumab 2Interleukin-12 Subunit p35 2Erlotinib Hydrochloride 2Cyclophosphamide 2Colonoscopy 2CTLA-4 Antigen 2tipifarnib 1tempol 1oncogene protein E7, Human papillomavirus type 16 1dehydroftorafur 1bintrafusp alfa protein, human 1X-Rays 1Watchful Waiting 1Tomography, X-Ray Computed 1Taxes 1Serotonin Plasma Membrane Transport Proteins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Anus Neoplasms × NHS-IL12 immunocytokine × Clear all
NCT04287868 2026-04-13

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
51 enrolled 16 charts
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡